ReidK, MoralesA, HarrisC. Double blind trial of yohimbine in treatment of psychogenic impotence. Lancet1987; i: 421–3
2.
MoralesA, CondraM, OwenJA, SurridgeDHC, FenemoreJ, HarrisC. Is yohimbine effective in the treatment of organic impotence? Results of a controlled trial. J Urol1987; 137: 1168–72
3.
RileyAJ, GoodmanRE, KellettJM, OrrR. Double blind trial of yohimbine hydrochloride in the treatment of erection inadequacy. Sex Marit Ther1989; 4: 17–26
4.
SussetJG, TesserCD, WinczeJ, BansalS, MalhotraC, SchwachaMG. Effect of yohimbine hydrochloride on erectile impotence; a double blind study. J Urol1989; 141: 1360–3
5.
WareJC, PittardJT, NadigPW, MorrisonJL, QuinnJB. Trazodone: its effects on nocturnal penile tumescence. Sleep Res1987; 16: 157
6.
KurtU, OzkardesH, AltugU, GermiyanogluC, GurdalM, ErolD. The effect of anti-serotonergic agents in the treatment of erectile dysfunction. J Urol1994; 152: 407–9
7.
CharneyDS, HeningerGR. α2-adrenergic and opiate receptor blockade. Arch Gen Psychiatry1986; 43: 1037–41
8.
GoldsteinJA. Erectile function and naltrexone. Ann Intern Med1986; 105: 799
9.
FabbriA, JanniniEA, GnessiL, MorettiC, UlisseS, FranzeseA. Endorphines in male impotence: evidence for naltrexone stimulation of erectile activity in patient therapy. Psychoneuroendocrinology1989; 14: 103–11
10.
GwinupG. Oral phentolamine in non-specific erectile insufficiency. Ann Intern Med1988; 109: 162–3
11.
HeatonJPW, AdamsMA, MoralesA, JohnstonB, El-RashidyR. A successful new oral treatment for non-organic erectile dysfunction—early results with apomorphine. Int J Impotence Res1994; 6(Suppl. 1):D76
12.
DabeesKL. Sublingual apomorphine for non-vascular impotence: dose evaluation study. Int J Impotence Res1994; 6(Suppl. 1):D75.
